These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16143488)

  • 1. In vivo evidence for an increase in 5alpha-reductase activity in the rat central nervous system following morphine exposure.
    Amini H; Ahmadiani A
    Int J Dev Neurosci; 2005 Nov; 23(7):621-6. PubMed ID: 16143488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5α-reductase 1 regulates spinal cord testosterone after morphine administration.
    Sharif A; Shoae-Hassani A; Sharif S; Banafshe HR; Mortazavi-Tabatabaei SA; Verdi J
    Neurol Sci; 2013 Jan; 34(1):19-23. PubMed ID: 22258359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in testosterone metabolism in the rat central nervous system by formalin-induced tonic pain.
    Amini H; Ahmadiani A
    Pharmacol Biochem Behav; 2002 Dec; 74(1):199-204. PubMed ID: 12376168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Stanczyk FZ; Azen CG; Pike MC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
    Dadras SS; Cai X; Abasolo I; Wang Z
    Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finasteride, a 5alpha-reductase inhibitor, potentiates antinociceptive effects of morphine, prevents the development of morphine tolerance and attenuates abstinence behavior in the rat.
    Verdi J; Ahmadiani A
    Horm Behav; 2007 May; 51(5):605-10. PubMed ID: 17428486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
    Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
    Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGP 53153: a new potent inhibitor of 5alpha-reductase.
    Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could the endogenous opioid, morphine, prevent neural stem cell proliferation?
    Shoae-Hassani A; Sharif S; Tabatabaei SA; Verdi J
    Med Hypotheses; 2011 Feb; 76(2):225-9. PubMed ID: 21051157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 5α-dihydrotestosterone in testicular development of gilthead seabream following finasteride administration.
    García-García M; Sánchez-Hernández M; García-Hernández MP; García-Ayala A; Chaves-Pozo E
    J Steroid Biochem Mol Biol; 2017 Nov; 174():48-55. PubMed ID: 28739284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
    Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
    J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a novel steroid (PM-9) on the inhibition of 5alpha-reductase present in Penicillium crustosum broths.
    Flores E; Cabeza M; Quiroz A; Bratoeff E; García G; Ramírez E
    Steroids; 2003 Mar; 68(3):271-5. PubMed ID: 12628690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.
    Zhu YS; Cai LQ; You X; Cordero JJ; Huang Y; Imperato-McGinley J
    J Androl; 2003; 24(5):681-7. PubMed ID: 12954658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
    Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
    Ranjan M; Diffley P; Stephen G; Price D; Walton TJ; Newton RP
    Life Sci; 2002 May; 71(2):115-26. PubMed ID: 12031682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.
    Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A
    Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.